Showing results (131-140 of 535) with videos related to
Sort By:
Pageof 54
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 13, 2007
High-performance liquid chromatography method with ultraviolet detection for the quantification of the BCR-ABL inhibitor nilotinib (AMN107) in plasma, urine, culture medium and cell preparationsS Pursche, O G Ottmann, G Ehninger, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1988
Synergistic inhibition of human marrow granulocyte-macrophage progenitor cells by prostaglandin E and recombinant interferon-alpha, -beta, and -gamma and an effect mediated by tumor necrosis factorL M Pelus, O G Ottmann, K H NockaBlood|November 26, 1999
A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemiaE Archimbaud, O G Ottmann, J A Yin, et al.Leukemia|November 15, 2014
PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutationA A Mian, A Rafiei, I Haberbosch, et al.Annals of Hematology|July 28, 1999
Association between structural and numerical chromosomal aberrations in acute myeloblastic leukemia: a study by RT-PCR and FISH in 447 patients with de-novo AMLJ Krauter, A Ganser, L Bergmann, et al.European Journal of Endocrinology|March 9, 1999
Kleine-Levin and Munchausen syndromes in a patient with recurrent acromegalyK Jungheim, K Badenhoop, O G Ottmann, et al.Leukemia|September 20, 2000
Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot studyW K Hofmann, W J Kell, P Fenaux, et al.Current Opinion in Hematology|May 1, 1995
Hematopoietic growth factors in the treatment of the myelodysplastic syndromesA GanserHuman Gene Therapy|August 7, 1998
Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cellsS Becker, S Wasser, M Hauses, et al.Blood|April 1, 1989
Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemiaE Thiel, B R Kranz, A Raghavachar, et al.Pageof 54